Search Results - "HUYETT, LAUREN M."

Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas by Huyett, Lauren M, Dassau, Eyal, Zisser, Howard C, Doyle, Francis J

“…Treatment of type 1 diabetes mellitus could be greatly improved by applying a closed-loop control strategy to insulin delivery, also known as an artificial…”
Get full text

Genomic analysis of methanogenic archaea reveals a shift towards energy conservation by Gilmore, Sean P, Henske, John K, Sexton, Jessica A, Solomon, Kevin V, Seppälä, Susanna, Yoo, Justin I, Huyett, Lauren M, Pressman, Abe, Cogan, James Z, Kivenson, Veronika, Peng, Xuefeng, Tan, YerPeng, Valentine, David L, O'Malley, Michelle A

“…The metabolism of archaeal methanogens drives methane release into the environment and is critical to understanding global carbon cycling. Methanogenesis…”
Get full text

Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System by Aleppo, Grazia, DeSalvo, Daniel J., Lauand, Felipe, Huyett, Lauren M., Chang, Albert, Vienneau, Todd, Ly, Trang T.

“…Introduction Despite recent advances in diabetes technology, most people living with type 1 diabetes mellitus (T1D) are unable to meet glycemic targets…”
Get full text

Glucose Sensing in the Peritoneal Space Offers Faster Kinetics Than Sensing in the Subcutaneous Space by BURNETT, Daniel R, HUYETT, Lauren M, ZISSER, Howard C, DOYLE, Francis J, MENSH, Brett D

“…The paramount goal in the treatment of type 1 diabetes is the maintenance of normoglycemia. Continuous glucose monitoring (CGM) technologies enable frequent…”
Get full text

Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms by DOYLE, Francis J, HUYETT, Lauren M, JOON BOK LEE, ZISSER, Howard C, DASSAU, Eyal

“…In this two-part Bench to Clinic narrative, recent advances in both the preclinical and clinical aspects of artificial pancreas (AP) development are described…”
Get full text

898-P: Real-World Glycemic Outcomes of >3,300 Children and Adolescents with Type 1 Diabetes Using the Omnipod 5 Automated Insulin Delivery (AID) System with Cloud-Based Data Management by SHERR, JENNIFER, DESALVO, DANIEL, HUYETT, LAUREN M., SNOW, KENNETH, MENDEZ, JOSE J., HADJIYIANNI, IRENE, LY, TRANG T.

“…The Omnipod 5 AID System is a novel tubeless hybrid closed-loop system that allows for personalized therapy through customizable glucose targets from…”
Get full text

57-OR: Real-World Glycemic Outcomes of >5,900 Adults with Type 1 Diabetes Using the Omnipod 5 Automated Insulin Delivery (AID) System with Cloud-Based Data Management by LAL, RAYHAN, ALEPPO, GRAZIA, HUYETT, LAUREN M., SNOW, KENNETH, MENDEZ, JOSE J., HADJIYIANNI, IRENE, LY, TRANG T.

“…The Omnipod 5 AID System is a novel tubeless hybrid closed-loop system that allows for personalized therapy through customizable glucose targets from…”
Get full text

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy by Davis, Georgia M, Peters, Anne L, Bode, Bruce W, Carlson, Anders L, Dumais, Bonnie, Vienneau, Todd E, Huyett, Lauren M, Ly, Trang T

“…Automated insulin delivery (AID) has rarely been studied in adults with type 2 diabetes. We tested the feasibility of using AID for type 2 diabetes with the…”
Get full text

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions by Sherr, Jennifer L, Buckingham, Bruce A, Forlenza, Gregory P, Galderisi, Alfonso, Ekhlaspour, Laya, Wadwa, R Paul, Carria, Lori, Hsu, Liana, Berget, Cari, Peyser, Thomas A, Lee, Joon Bok, O'Connor, Jason, Dumais, Bonnie, Huyett, Lauren M, Layne, Jennifer E, Ly, Trang T

“…The objective of this study was to assess the safety and performance of the Omnipod personalized model predictive control (MPC) algorithm in adults,…”
Get more information

897-P: Real-World Glycemic Outcomes of >400 Adults with Type 2 Diabetes Using the Omnipod 5 Automated Insulin Delivery (AID) System with Cloud-Based Data Management by PETERS, ANNE L., PASQUEL, FRANCISCO J., HUYETT, LAUREN M., SNOW, KENNETH, MENDEZ, JOSE J., HADJIYIANNI, IRENE, LY, TRANG T.

“…The Omnipod 5 AID System is a novel tubeless hybrid closed-loop system approved for use in people with type 1 diabetes ages 2 and up and was recently evaluated…”
Get full text

Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system by Carlson, Anders L., Huyett, Lauren M., Jantz, Jay, Chang, Albert, Vienneau, Todd, Ly, Trang T.

“…•There have been few studies of insulin pump therapy in people with T2DM.•HbA1c was lower 90 days after initiating Omnipod insulin pump in those with…”
Get full text

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study by Dassau, Eyal, Renard, Eric, Place, Jérôme, Farret, Anne, Pelletier, Marie‐José, Lee, Justin, Huyett, Lauren M., Chakrabarty, Ankush, Doyle, Francis J., Zisser, Howard C.

“…Aims To compare intraperitoneal (IP) to subcutaneous (SC) insulin delivery in an artificial pancreas (AP). Research design and methods Ten adults with type 1…”
Get full text

702-P: Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use by DESALVO, DANIEL, ALEPPO, GRAZIA, LAUAND, FELIPE, HUYETT, LAUREN M., JANTZ, JAY, CHANG, ALBERT, VIENNEAU, TODD, LY, TRANG T.

“…Clinical outcomes describing real-world use of various devices by people with T1D are important to support decision-making. This retrospective study…”
Get full text

Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes by Forlenza, Gregory P, DeSalvo, Daniel J, Aleppo, Grazia, Wilmot, Emma G, Berget, Cari, Huyett, Lauren M, Hadjiyianni, Irene, Méndez, José J, Conroy, Lindsey R, Ly, Trang T, Sherr, Jennifer L

“…The Omnipod 5 Automated Insulin Delivery System was associated with favorable glycemic outcomes for people with type 1 diabetes (T1D) in two pivotal clinical…”
Get more information

First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes by Forlenza, Gregory P, Buckingham, Bruce A, Brown, Sue A, Bode, Bruce W, Levy, Carol J, Criego, Amy B, Wadwa, R Paul, Cobry, Erin C, Slover, Robert J, Messer, Laurel H, Berget, Cari, McCoy, Susan, Ekhlaspour, Laya, Kingman, Ryan S, Voelmle, Mary K, Boyd, Jennifer, O'Malley, Grenye, Grieme, Aimee, Kivilaid, Kaisa, Kleve, Krista, Dumais, Bonnie, Vienneau, Todd, Huyett, Lauren M, Lee, Joon Bok, O'Connor, Jason, Benjamin, Eric, Ly, Trang T

“…The objective of this study was to assess the safety and effectiveness of the first commercial configuration of a tubeless automated insulin delivery system,…”
Get more information

Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 automated insulin delivery system by Davis, Georgia M, Peters, Anne L, Bode, Bruce W, Carlson, Anders L, Dumais, Bonnie, Vienneau, Todd E, Huyett, Lauren M, Ly, Trang T

“…The aim was to evaluate the effect of extended use of the Omnipod® 5 automated insulin delivery (AID) system in adults with type 2 diabetes and suboptimal…”
Get full text

Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia by Dassau, Eyal, Pinsker, Jordan E., Kudva, Yogish C., Brown, Sue A., Gondhalekar, Ravi, Dalla Man, Chiara, Patek, Steve, Schiavon, Michele, Dadlani, Vikash, Dasanayake, Isuru, Church, Mei Mei, Carter, Rickey E., Bevier, Wendy C., Huyett, Lauren M., Hughes, Jonathan, Anderson, Stacey, Lv, Dayu, Schertz, Elaine, Emory, Emma, McCrady-Spitzer, Shelly K., Jean, Tyler, Bradley, Paige K., Hinshaw, Ling, Laguna Sanz, Alejandro J., Basu, Ananda, Kovatchev, Boris, Cobelli, Claudio, Doyle, Francis J.

“…OBJECTIVEArtificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient…”
Get full text

How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System by Polonsky, William H., Hood, Korey K., Levy, Carol J., MacLeish, Sarah A., Hirsch, Irl B., Brown, Sue A., Bode, Bruce W., Carlson, Anders L., Shah, Viral N., Weinstock, Ruth S., Bhargava, Anuj, Jones, Thomas C., Aleppo, Grazia, Mehta, Sanjeev N., Laffel, Lori M., Forlenza, Gregory P., Sherr, Jennifer L., Huyett, Lauren M., Vienneau, Todd E., Ly, Trang T.

“…•Adults with T1D used an investigational tubeless Omnipod 5 AID system for 3 months.•Participants saw improvements in diabetes-related psychosocial outcomes…”
Get full text

992-P: Patient-Reported Outcomes for 2,335 Adults with Type 2 Diabetes Using the Omnipod Insulin Management System Show Glycemic Improvement over First 90 Days of Use by CARLSON, ANDERS L., HUYETT, LAUREN M., JANTZ, JAY, CHANG, ALBERT, VIENNEAU, TODD, LY, TRANG T.

“…Patient-reported outcomes are a useful tool to understand the impact of treatments in clinical application on a large scale. This retrospective study…”
Get full text

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial by Forlenza, Gregory P, Deshpande, Sunil, Ly, Trang T, Howsmon, Daniel P, Cameron, Faye, Baysal, Nihat, Mauritzen, Eric, Marcal, Tatiana, Towers, Lindsey, Bequette, B Wayne, Huyett, Lauren M, Pinsker, Jordan E, Gondhalekar, Ravi, Doyle, 3rd, Francis J, Maahs, David M, Buckingham, Bruce A, Dassau, Eyal

“…As artificial pancreas (AP) becomes standard of care, consideration of extended use of insulin infusion sets (IIS) and continuous glucose monitors (CGMs)…”
Get full text